Literature DB >> 20134148

Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.

Mario Cazzola1, Germano Bettoncelli, Emiliano Sessa, Claudio Cricelli, Gianluca Biscione.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with many comorbidities, but the percentage of COPD patients who develop comorbidities has not been clearly defined.
OBJECTIVES: We aimed to examine the relationship between COPD and comorbidities using information obtained from the Health Search Database (HSD) owned by the Italian College of General Practitioners (SIMG), which stores information on about 1.5% of the total Italian population served by general practitioners.
METHODS: We conducted a population-based retrospective study using information obtained from the HSD. The software system used codes all the diagnostic records using the 9th Revision of the International Classification of Diseases.
RESULTS: Compared to the non-COPD people, COPD patients were at increased risk for cardiovascular events [ischemic heart disease (6.9% in the general population vs. 13.6% in COPD patients), cardiac arrhythmia (6.6% in the general population vs. 15.9% in COPD patients), heart failure (2.0% in the general population vs. 7.9% in COPD patients), and other forms of heart disease (10.7% in the general population vs. 23.1% in COPD patients); with a higher impact of COPD in the elderly]; non-psychotic mental disorders, including depressive disorders (29.1% in the general population vs. 41.6% in COPD patients; with a higher impact of COPD on women aged <75 years); diabetes mellitus (10.5% in the general population vs. 18.7% in COPD patients); osteoporosis (10.8% in the general population vs. 14.8% in COPD patients), with a higher impact of COPD on women aged <75 years, and malignant pulmonary neoplasms (0.4% in the general population vs. 1.9% in COPD patients).
CONCLUSIONS: Our results indicate that COPD is a risk factor for these comorbid conditions. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20134148     DOI: 10.1159/000281880

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  54 in total

Review 1.  Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update.

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

Review 2.  Ageing and the epidemiology of multimorbidity.

Authors:  Miguel J Divo; Carlos H Martinez; David M Mannino
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

3.  A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.

Authors:  A Afonso; S Schmiedl; C Becker; S Tcherny-Lessenot; P Primatesta; E Plana; P Souverein; Y Wang; J C Korevaar; J Hasford; R Reynolds; M C H de Groot; R Schlienger; O Klungel; M Rottenkolber
Journal:  Eur J Clin Pharmacol       Date:  2016-05-24       Impact factor: 2.953

Review 4.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 5.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 6.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Authors:  Donald P Tashkin; Leonardo M Fabbri
Journal:  Respir Res       Date:  2010-10-29

7.  Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Authors:  Yasuhiko Kubota; Aaron R Folsom; Kunihiro Matsushita; David Couper; Weihong Tang
Journal:  Atherosclerosis       Date:  2017-10-13       Impact factor: 5.162

8.  Network medicine analysis of COPD multimorbidities.

Authors:  Solène Grosdidier; Antoni Ferrer; Rosa Faner; Janet Piñero; Josep Roca; Borja Cosío; Alvar Agustí; Joaquim Gea; Ferran Sanz; Laura I Furlong
Journal:  Respir Res       Date:  2014-09-24

9.  Associations of Self-Reported Cigarette Smoking with Chronic Obstructive Pulmonary Disease and Co-Morbid Chronic Conditions in the United States.

Authors:  Timothy J Cunningham; Earl S Ford; Italia V Rolle; Anne G Wheaton; Janet B Croft
Journal:  COPD       Date:  2014-09-10       Impact factor: 2.409

10.  Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010.

Authors:  Anne G Wheaton; Earl S Ford; Timothy J Cunningham; Janet B Croft
Journal:  J Aging Health       Date:  2014-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.